AllianceBernstein’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Hold
99,550
﹤0.01% 2250
2025
Q4
$1.24M Buy
99,550
+19,310
+24% +$257K ﹤0.01% 2250
2025
Q3
$1.15M Hold
80,240
﹤0.01% 2280
2025
Q2
$985K Sell
80,240
-2,626,194
-97% -$38.1M ﹤0.01% 2296
2025
Q1
$59.5M Buy
2,706,434
+128,041
+5% +$3.01M 0.02% 542
2024
Q4
$58.5M Sell
2,578,393
-443,597
-15% -$9.68M 0.02% 554
2024
Q3
$54.9M Sell
3,021,990
-68,033
-2% -$1.58M 0.02% 582
2024
Q2
$90M Sell
3,090,023
-130,268
-4% -$3.86M 0.03% 435
2024
Q1
$114M Buy
3,220,291
+494,789
+18% +$19.8M 0.04% 372
2023
Q4
$119M Sell
2,725,502
-67,329
-2% -$2.65M 0.05% 353
2023
Q3
$107M Sell
2,792,831
-83,697
-3% -$3.52M 0.05% 361
2023
Q2
$118M Sell
2,876,528
-57,086
-2% -$2.75M 0.05% 342
2023
Q1
$168M Buy
2,933,614
+36,981
+1% +$2.08M 0.07% 255
2022
Q4
$162M Buy
2,896,633
+384,941
+15% +$19.6M 0.07% 252
2022
Q3
$106M Buy
2,511,692
+128,567
+5% +$6.59M 0.05% 339
2022
Q2
$129M Buy
2,383,125
+103,883
+5% +$6.24M 0.06% 288
2022
Q1
$146M Sell
2,279,242
-50,118
-2% -$3.3M 0.06% 312
2021
Q4
$156M Buy
2,329,360
+231,383
+11% +$15.7M 0.06% 319
2021
Q3
$144M Buy
2,097,977
+1,986,060
+1,775% +$140M 0.06% 321
2021
Q2
$7.64M Sell
111,917
-1,760
-2% -$124K ﹤0.01% 1378
2021
Q1
$7.85M Buy
113,677
+1,510
+1% +$102K ﹤0.01% 1325
2020
Q4
$7.28M Sell
112,167
-2,706
-2% -$146K ﹤0.01% 1293
2020
Q3
$5.42M Sell
114,873
-1,744
-1% -$83K ﹤0.01% 1303
2020
Q2
$5.48M Sell
116,617
-2,210
-2% -$109K ﹤0.01% 1276
2020
Q1
$5.31M Sell
118,827
-1,150
-1% -$60.3K ﹤0.01% 1150
2019
Q4
$6.99M Buy
119,977
+4,340
+4% +$258K ﹤0.01% 1240
2019
Q3
$6.95M Sell
115,637
-1,855
-2% -$111K ﹤0.01% 1202
2019
Q2
$6.56M Sell
117,492
-2,050
-2% -$106K ﹤0.01% 1255
2019
Q1
$6.66M Sell
119,542
-90
-0.1% -$4.58K ﹤0.01% 1229
2018
Q4
$5.39M Buy
119,632
+79,270
+196% +$4.35M ﹤0.01% 1262
2018
Q3
$2.66M Sell
40,362
-610
-1% -$37.9K ﹤0.01% 1741
2018
Q2
$2.64M Sell
40,972
-51,344
-56% -$3.18M ﹤0.01% 1727
2018
Q1
$5.11M Sell
92,316
-800
-0.9% -$41.9K ﹤0.01% 1207
2017
Q4
$4.46M Sell
93,116
-1,400
-1% -$68.5K ﹤0.01% 1288
2017
Q3
$4.77M Hold
94,516
﹤0.01% 1240
2017
Q2
$5.15M Sell
94,516
-6,300
-6% -$301K ﹤0.01% 1195
2017
Q1
$4.25M Sell
100,816
-1,600
-2% -$68.4K ﹤0.01% 1288
2016
Q4
$4.39M Hold
102,416
﹤0.01% 1270
2016
Q3
$4.23M Hold
102,416
﹤0.01% 1205
2016
Q2
$4.08M Buy
102,416
+17,400
+20% +$626K ﹤0.01% 1166
2016
Q1
$2.86M Hold
85,016
﹤0.01% 1351
2015
Q4
$2.88M Hold
85,016
﹤0.01% 1357
2015
Q3
$2.53M Sell
85,016
-26,440
-24% -$827K ﹤0.01% 1467
2015
Q2
$3.07M Sell
111,456
-2,936
-3% -$78.2K ﹤0.01% 1440
2015
Q1
$2.88M Hold
114,392
﹤0.01% 1469
2014
Q4
$2.54M Sell
114,392
-3,714
-3% -$75.3K ﹤0.01% 1567
2014
Q3
$2.4M Hold
118,106
﹤0.01% 1578
2014
Q2
$2.27M Buy
118,106
+3,425
+3% +$63.8K ﹤0.01% 1678
2014
Q1
$2.16M Sell
114,681
-3,425
-3% -$66.1K ﹤0.01% 1651
2013
Q4
$2.3M Hold
118,106
﹤0.01% 1605
2013
Q3
$1.94M Sell
118,106
-1,913
-2% -$30.7K ﹤0.01% 1696
2013
Q2
$1.8M Buy
+120,019
New +$1.76M ﹤0.01% 1678

Other funds holding IART

AllianceBernstein's IART Position: Q1 2026 in Review

AllianceBernstein held its Integra LifeSciences (IART) position steady in Q1 2026 at 99,550 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2250.

AllianceBernstein first reported a position in IART in Q2 2013 and has held it in 52 quarters since. The position peaked at $168M in Q1 2023. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • AllianceBernstein held 99,550 shares of Integra LifeSciences worth $1.24M as of Q1 2026.
  • AllianceBernstein left its Integra LifeSciences share count unchanged in Q1 2026.
  • Integra LifeSciences made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2250 holding.
  • AllianceBernstein first reported a position in Integra LifeSciences in Q2 2013 and has held it in 52 quarters since.
  • AllianceBernstein's Integra LifeSciences position peaked at $168M in Q1 2023.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.